Workflow
AFC Gamma(AFCG)
icon
Search documents
AFC Gamma Inc. (AFCG) Lags Q4 Earnings and Revenue Estimates
Zacks Investment Research· 2024-03-07 15:46
AFC Gamma Inc. (AFCG) came out with quarterly earnings of $0.49 per share, missing the Zacks Consensus Estimate of $0.50 per share. This compares to earnings of $0.62 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -2%. A quarter ago, it was expected that this company would post earnings of $0.48 per share when it actually produced earnings of $0.49, delivering a surprise of 2.08%.Over the last four quarters, the company has s ...
AFC Gamma, Inc. Announces Financial Results for Fourth Quarter and Full Year 2023
Newsfilter· 2024-03-07 13:33
Fourth quarter 2023 GAAP net loss of $(9.2) million or $(0.45) per basic weighted average common share andDistributable Earnings(1) of $10.0 million or $0.49 per basic weighted average common share Full year 2023 GAAP net income of $21.0 million or $1.02 per basic weighted average common share andDistributable Earnings of $41.4 million or $2.04 per basic weighted average common share Declared dividend of $0.48 per common share for first quarter 2024 WEST PALM BEACH, Fla., March 07, 2024 (GLOBE NEWSWIRE) -- ...
AFC Gamma(AFCG) - 2023 Q4 - Annual Report
2024-03-06 16:00
Loan Origination and Pipeline - As of March 1, 2024, the loan origination pipeline includes potential new loans to commercial real estate owners and cannabis operators, with total prospective loan commitments of approximately $701 million and $279 million, respectively[35]. - From January 1, 2020 to March 1, 2024, the management team sourced over $19.4 billion of loans across the cannabis industry while maintaining a robust pipeline of actionable opportunities[35]. - As of March 1, 2024, the company had 29 active loans in the commercial real estate pipeline and 10 active loans in the cannabis pipeline, having passed on 396 and 752 loan opportunities respectively due to various risk factors[114]. - The company has access to over $19.4 billion in potential loan opportunities from January 1, 2020, to December 31, 2023, primarily targeting cannabis operators[108]. Management Agreement and Structure - The management agreement automatically renews every year on July 31 for a one-year period unless either party elects not to renew[43]. - The management agreement allows for an internalization transaction if the company's equity equals or exceeds $1 billion, with a specified internalization price formula[43]. - The management agreement has been amended multiple times to update investment guidelines, including allowing investments in first and second lien loans secured by mortgages to cannabis operators[49]. - The Management Agreement allows for termination by the company with 30 days' notice if the Manager breaches material provisions, with specific conditions for cure periods[53]. - The company may terminate the Management Agreement with 60 days' notice if it defaults on material terms, requiring payment of a Termination Fee[54]. - An Internalization Transaction can occur when the company's equity exceeds $1 billion, allowing the Manager to contribute its assets or equity to the company[55]. - The Internalization Price is determined based on five times the sum of the annual Base Management Fee, annual Incentive Compensation, and aggregate Outside Fees earned in the previous 12 months[56]. Financial Performance and Management Fees - For the years ended December 31, 2023 and 2022, the Manager earned a Base Management Fee of approximately $3.7 million and $3.4 million respectively, net of a Base Management Fee Rebate of approximately $1.7 million and $1.8 million[81]. - The Incentive Compensation fee payable to the Manager for the years ended December 31, 2023 and 2022 was approximately $10.4 million and $12.3 million respectively[81]. - Total management fees for the year ended December 31, 2023 amounted to $17,654,899, a decrease from $19,741,562 in 2022[83]. - Base management fees for 2023 were $3,702,484 compared to $3,427,619 in 2022, reflecting an increase of approximately 8%[83]. - Incentive fees earned in 2023 were $10,361,821, down from $12,337,631 in 2022, indicating a decrease of approximately 16%[83]. - General and administrative expenses reimbursable to the Manager for 2023 were $3,590,594, compared to $3,976,312 in 2022, showing a reduction of approximately 10%[83]. - The Base Management Fees were amended to 0.375% of Equity, down from 0.4375%[84]. - The Hurdle Amount for Incentive Compensation is now set at 2% of Adjusted Capital as of the last day of the preceding fiscal quarter[88]. - The Clawback Obligation requires the Manager to pay back Incentive Compensation if Core Earnings do not exceed 8% of Adjusted Capital for the fiscal year[92]. - The total management fees for 2023 reflect a strategic focus on cost management and efficiency improvements[83]. Loan Portfolio and Risk Management - The company has a portfolio where approximately 68% of loans are tied to variable rates based on SOFR or U.S. prime rate as of December 31, 2023[658]. - The company actively manages risk exposure by monitoring financing, interest rate, credit, prepayment, and convexity risks associated with its portfolio[655]. - The company believes it has a competitive advantage due to its Manager's financing industry expertise and flexible funding structure compared to traditional REIT models[118]. - The company operates in a highly regulated lending environment, particularly due to its involvement in the cannabis industry, which is subject to various federal and state laws[120]. - The company faces significant competition from larger institutional investors, which may impact its ability to secure attractive lending opportunities[117]. - The company’s operations are influenced by the Dodd-Frank Act, which has introduced various regulations affecting the financial services industry[121]. - The company primarily provides loans to the cannabis industry, which involves significant risks due to federal illegality and potential regulatory changes[674]. - The company intends to monitor the legal landscape to mitigate risks associated with its loan portfolio[676]. Loan Commitments and Amendments - The company has a senior secured loan facility with Private Company I, with an aggregate loan commitment of $15.5 million, which has undergone several amendments since its inception[66]. - In September 2021, the company entered into a commitment to make loans to Private Company A totaling $20.0 million, which was subsequently increased through multiple amendments, reaching a total of $66.3 million by March 2023[68]. - The credit agreement with Subsidiary of Private Company G was amended to increase total loan commitments to $73.5 million, with an interest rate adjustment from 13.7% to U.S. prime rate plus 10.25%[70]. - The credit agreement with Subsidiary of Public Company H was amended to increase total loan commitments to $84.0 million, with an interest rate adjustment to U.S. prime rate plus 5.8%[70]. - The company entered into a secured mezzanine loan with CRE Private Company A in January 2024, consisting of $56.4 million in loan commitments, with $28.2 million funded by the company[72]. - The secured mezzanine loan with CRE Private Company B was also established in January 2024, with $56.4 million in loan commitments, of which $20.7 million was funded by the company[73]. Interest Rate and Market Conditions - The company is subject to interest rate risk, which could lead to a decline in net interest spread and net interest margin during periods of rising interest rates[664]. - A hypothetical 100 basis points increase in the floating benchmark rate would result in an increase in annual interest income of approximately $2.7 million[665]. - The fair value of loans may fluctuate due to market conditions, with a decrease of 50 basis points resulting in an unrealized gain (loss) of approximately $0.3 million[665]. - The company is closely monitoring the transition from LIBOR to alternative benchmarks, with potential impacts on financing costs and net investment income[656].
AFC Gamma(AFCG) - 2023 Q4 - Annual Results
2024-03-06 16:00
AFC Gamma, Inc. Announces Financial Results for Fourth Quarter and Full Year 2023 Common Stock Dividend On December 15, 2023, the Company's Board of Directors declared a regular cash dividend of $0.48 per common share for the fourth quarter of 2023. For the fourth quarter of 2023, AFC Gamma distributed $9.8 million in dividends, or $0.48 per common share, compared to Distributable Earnings of $0.49 per basic weighted average common share for such period. For the full year 2023, AFC Gamma distributed $40.9 m ...
Best Cannabis REITs for Investors Watchlist In 2024
MarijuanaStocks· 2024-02-08 19:20
Industry Overview - The U.S. cannabis industry is projected to grow significantly, with an expected value exceeding $30 billion by 2025, driven by increasing legalization and acceptance [2][20] - Cannabis Real Estate Investment Trusts (REITs) are gaining attention as they provide exposure to the cannabis market through real estate without direct involvement in cultivation or sales [1][20] Company Highlights: Innovative Industrial Properties, Inc. (IIP) - IIP focuses on medical cannabis facilities and has acquired 111 properties across 19 states, primarily in California, Michigan, and Pennsylvania [3][4] - The company reported a 10% increase in total revenues from $70.9 million in 2022 to approximately $77.8 million in Q3 2023, driven by new property acquisitions and increased tenant contributions [5][6] - IIP's Funds from Operations (FFO) for the first nine months of 2023 was $173.2 million, translating to $6.13 per share, with an annual dividend increase of 6% to $7.20 per common share [6][8] Financial Performance: AFC Gamma, Inc. - AFC Gamma reported a net income of $8.0 million, or $0.39 per share, for Q3 2023, with distributable earnings of $9.9 million, or $0.49 per share [11][12] - The company paid a regular cash dividend of $0.48 per common share for Q3 2023, distributing a total of $9.8 million in dividends [12] Company Highlights: Chicago Atlantic Real Estate Finance, Inc. (REFI) - REFI specializes in providing loan solutions and real estate capital to cannabis operators, with a significant portfolio in key states like Illinois, California, and Michigan [14][15] - The company forecasts a net interest income of approximately $13.7 million for Q3 2023, maintaining total expenses consistent with the previous quarter [15][16] - As of September 30, 2023, REFI's book value per common share increased to $15.17, and the company expects to maintain a dividend payout ratio of approximately 90% to 100% for the full year [17][18] Stock Performance - IIPR stock closed at $89.96 on February 7, 2024, down 5.11% over the last month and down 10.77% year to date [8] - AFCG shares closed at $11.24 on February 7, 2024, reflecting a 6.02% decrease from the previous month [13] - REFI stock closed at $15.54 on February 7, 2024, down 2.48% in the last month and down 3.96% year to date [19]
AFC Gamma, Inc. Schedules Fourth Quarter and Annual 2023 Earnings Conference Call for March 7, 2024
Newsfilter· 2024-01-31 22:00
Company Overview - AFC Gamma, Inc. is a publicly-traded institutional lender that specializes in originating, structuring, and underwriting loans secured by commercial real estate and other financing solutions [2] - The company targets direct lending and bridge loan opportunities typically ranging from $5 million to $100 million across multiple real estate sectors, with a specialization in lending to state-law compliant cannabis operators [2] Upcoming Financial Reporting - AFC Gamma plans to report earnings for the quarter and fiscal year ended December 31, 2023, on Thursday, March 7, 2024 [1] - A conference call will be held at 10:00 am Eastern Time on the same day to discuss the quarterly and annual financial results, and all interested parties are welcome to participate [1] - The call will be available through a live audio webcast on the Investor Relations section of AFC Gamma's website [1]
When You Lay Down With Dogs, You Wake Up With Fleas
Seeking Alpha· 2024-01-12 12:00
Core Insights - The article emphasizes the importance of management quality in investment decisions, particularly in the context of Real Estate Investment Trusts (REITs) [4][5][30] - It highlights specific challenges faced by Medical Properties Trust, Inc. (MPW), including high leverage, tenant concentration, and management issues, which have led to significant stock price declines [9][10][14] Company Analysis: Medical Properties Trust, Inc. (MPW) - MPW is a healthcare-focused REIT with a market cap of approximately $2.0 billion and a portfolio of 437 properties, primarily general acute care hospitals [6][9] - The company has experienced a stock price decline of 85.25% from January 14, 2022, to January 10, 2024, and has lost nearly 30% year-to-date [7][9] - MPW's adjusted funds from operations (AFFO) are expected to fall by 11% in 2023 and by 17% in 2024, with a significant dividend cut of nearly 50% in 2023 [14] Financial Performance and Issues - MPW's tenant concentration is notably high, with Steward Health Care accounting for approximately 20% of its total assets and revenue [10][14] - The company has faced allegations of unethical practices, including inflating asset values and excessive spending, which have raised concerns about management integrity [9][10] - As of the end of 2023, MPW reported unpaid rent from Steward totaling approximately $50 million, prompting the issuance of a new $60 million loan to the tenant [14] Industry Context: Real Estate Investment Trusts (REITs) - The REIT sector has been adversely affected by rising interest rates and inflation, impacting overall performance [9] - Despite the challenges, the article suggests that there are well-managed REITs worth investing in, emphasizing the need for careful selection based on management quality [5][30] - The article warns against investing in poorly managed REITs, as they can lead to significant financial losses [5][30]
Cannabis Investing: 3 Top Marijuana Stocks For 2024
MarijuanaStocks· 2024-01-11 12:00
The Best 3 Marijuana Stocks To Buy In The Market TodayWith 2024 underway marijuana stocks are starting to show better trading action. Even with volatility still showing there have been more signs of life for the sector. What this means is some pot stocks are showing up and down trading consistency. Which did not occur often back in 2023 it was either a downtrend or a short recovery in trading. Nevertheless, there is much speculation on what will take place this year.There are several important situations th ...
AFC Gamma: How Sustainable Is The 16% Dividend Yield?
Seeking Alpha· 2024-01-02 06:03
Olga Tsareva AFC Gamma's (NASDAQ:AFCG) quarterly dividend distributions proved somewhat resilient in 2023. Whilst there was a 14.3% dividend cut in June, the cannabis lender has been able to keep its quarterly distributions stable through the rest of a year that saw cannabis companies face material headwinds. Acreage (OTCQX:ACRHF), previously one of its top borrowers, lost 75% of its value and is currently teetering on the brink of a Chapter 11 bankruptcy filing with a $17 million market cap set against lon ...
Top Marijuana Stocks To Watch As 2024 Soon Begins
MarijuanaStocks· 2023-12-29 13:29
Find Out If These Are The Best Cannabis Stocks For YouCannabis stock investors are preparing for the new year. In 2023 investors were getting more comfortable with how volatility has affected the sector. Now from 2020-2022 the way volatility hit marijuana stocks created a lot more uncertainty when trading. It seems that the way to give people more confidence to invest is to change several things. For starters, the main issue is not having better laws and regulations.Some investors feel that with no federal ...